Hydroxycholecalciferols [clinicaltrials_resource:33c709ab08c87deff0257a5d270f412e]
Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. [clinicaltrials:NCT00138983]A New Active Vitamin D, ED-71 for Osteoporosis [clinicaltrials:NCT00144456]Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study) [clinicaltrials:NCT00168909]Treatment of Secondary Hyperparathyroidism in the Uremic Patient [clinicaltrials:NCT00469599]Fall Prevention by Alfacalcidol and Training [clinicaltrials:NCT00483275]clinicaltrials:NCT00640237Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00668330]Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients [clinicaltrials:NCT00798993]Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT) [clinicaltrials:NCT00828347]The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure [clinicaltrials:NCT00832533]Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels [clinicaltrials:NCT00910260]The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA) [clinicaltrials:NCT01020253]Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism [clinicaltrials:NCT01115543]The Influence of Proton Pump Inhibitors (PPI's) on Blood Levels of 25-Hydroxyvitamin D. [clinicaltrials:NCT01302704]Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease [clinicaltrials:NCT01364688]Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults [clinicaltrials:NCT01398202]The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3 [clinicaltrials:NCT01633658]Assessing the Effects of Alfacalcidol Intake on Expression of Involed Gene in Metabolism in Obese Subjects [clinicaltrials:NCT01752244]The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels [clinicaltrials:NCT01765010]Measurement of the Free Fraction of 25-hydroxyvitamin D in Serum [clinicaltrials:NCT01771380]clinicaltrials:NCT01774812Assessment Vitamin D Analogues Intake Pathways on the Proteins Which Involved in Metabolic Rate in Obese Subjects [clinicaltrials:NCT01894295]Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol [clinicaltrials:NCT01974167]clinicaltrials:NCT02063334Vitamin D and Outcome in Cardiac Surgery [clinicaltrials:NCT02192528]clinicaltrials:NCT02293187The Effect of Alfacalcidol on Muscle Strength in Elderly Indonesian Women : A Randomized Controlled Trial [clinicaltrials:NCT02327091]Vitamin D and Mortality: an Individual Participant Data Meta-analysis of Standardized 25-hydroxyvitamin D [clinicaltrials:NCT02438488]Role of Vitamin D Levels (Serum 25-hydroxyvitamin D) and Cognitive Impairment in the Occurrence of Falls [clinicaltrials:NCT02517164]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Hydroxycholecalciferols [clinicaltrials_resource:33c709ab08c87deff0257a5d270f412e]
Bio2RDF identifier
33c709ab08c87deff0257a5d270f412e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:33c709ab08c87deff0257a5d270f412e
identifier
clinicaltrials_resource:33c709ab08c87deff0257a5d270f412e
title
Hydroxycholecalciferols
@en
type
label
Hydroxycholecalciferols [clinicaltrials_resource:33c709ab08c87deff0257a5d270f412e]
@en